Technology | October 07, 2008

Philips Highlights SPECT/CT, PET/CT

Philips Highlights SPECT/CT, PET/CT

The Philips BrightView XCT integrates Philips BrightView SPECT in a co-planar design with advanced flat-detector X-ray CT technology to acquire low-dose, high-resolution CT images and to improve registration confidence. The system represents the first time a flat panel X-ray detector will be used for CT imaging in nuclear medicine.

The BrightView XCT features technological advances that can enable low patient dose levels, high-resolution localization and high-quality attenuation correction with the potential for fewer artifacts and shorter exam times. This offers clinical advantages particularly in cardiology studies, the top procedure in nuclear medicine. In addition, the co-planar SPECT and CT capabilities limit, and in some cases eliminate, the need to move the table between scans. Reduced movement can help improve patient comfort and allow for more confidence in image registration, the process of comparing, matching and superimposing the SPECT and CT images on one another for analysis. The BrightView XCT is also the only scalable SPECT and SPECT/CT system that fits into a 12-inch by 15.5-inch room and does not require special certification for nuclear medicine technicians.

Additionally, Philips will showcase the new GEMINI TF PET/CT and GEMINI TF PET/CT Big Bore, which features 4D time-of-flight technology, a toolkit to better manage respiratory motion by offering comprehensive tools for combined CT, PET and PET/CT correlated imaging.

The new Philips GEMINI TF Big Bore is the first commercial Big Bore PET/CT, with a full 85 cm bore diameter for both PET and CT scans. The system combines Philips time-of-flight PET imaging technologies with its Brilliance CT Big Bore simulation to optimize oncology workflow, accuracy and patient experience. The GEMINI TF PET/CT Big Bore system is designed to meet the requirements of radiation oncology applications, providing improved planning in cases that call for patients to be in extended positions, such as with treatments of breast and colorectal cancers. The system allows patients to be positioned for simulation in the same manner as they would to receive therapy.

Related Content

Siemens Healthineers Announces First U.S. Install of Biograph Vision PET/CT
News | PET-CT | March 06, 2019
Siemens Healthineers’ new Biograph Vision positron emission tomography/computed tomography (PET/CT) system has been...
News | PET-CT | February 06, 2019
Technological advancements in positron emission tomography/computed tomography (PET/CT) offer both clinicians and pat
FDA Clears United Imaging Healthcare uExplorer Total-Body Scanner
Technology | PET-CT | January 23, 2019
January 23, 2019 — United Imaging Healthcare (United Imaging) announced U.S.
Videos | SPECT-CT | December 12, 2018
This is a walk around of the new Spectrum Dynamics Veriton SPECT-CT nuclear imaging system introduced at the 2018 ...
Spectrum Dynamics Sues GE for Theft, Misappropriation of Trade Secrets and Unfair Competition
News | SPECT Imaging | December 06, 2018
Single-photon emission computed tomography (SPECT) cardiac imaging company Spectrum Dynamics filed a lawsuit Dec. 6,...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Siemens Healthineers Showcases syngo Virtual Cockpit for More Flexible Workforce Management
News | Teleradiology | November 25, 2018
During the 104th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 25-30...
A PET/CT head and neck cancer scan.

A PET/CT head and neck cancer scan.

Feature | Nuclear Imaging | November 05, 2018 | By Sabyasachi Ghosh
“Experimental validation implemented in real-life situations and not theoretical claims exaggerating small advantages
Bruker Introduces New High-Performance Preclinical PET/CT Si78 System
Technology | PET-CT | September 26, 2018
September 26, 2018 — Bruker recently announced the introduction of the new preclinical...